RecruitingNCT04579588

Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Sponsor

Stanford University

Enrollment

230 participants

Start Date

Oct 29, 2020

Study Type

OBSERVATIONAL

Conditions

Immunity Corona Virus Infection Flu Vaccine

Summary

The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 9 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.

Eligibility

Min Age: 9 YearsMax Age: 64 Years

Inclusion Criteria4

Age 9 through 64 years
Diagnosed with COVID-19 at least 2 months prior enrollment
Patients with or without obesity, diabetes, chronic fatigue and/or long term COVID-19 symptoms
Patients without COVID-19 diagnosis for controls

Exclusion Criteria6

Received the influenza vaccine less than 4 months ago
Pregnant or lactating
Patients with special risks attendant to venipuncture
Use of immunomodulatory medications that may impact vaccine immune response per clinician's judgment
Contraindication to the flu vaccine
Immunodeficiency or autoimmune disease that may impact vaccine immune responses per clinician's judgement

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.